We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New AI Software Accurately Detects Lung Cancers on X-Rays and Cuts Unnecessary Chest CT Scans by 30%

By HospiMedica International staff writers
Posted on 06 Aug 2021
A recent study has shown that a deep learning-based artificial intelligence (AI) algorithm can improve the performance of readers in detecting lung cancers on chest radiographs.

According to the second joint study conducted by Massachusetts General Hospital (Boston, MA, USA) and Lunit Inc. More...
(Seoul, Korea), AI had 28% sensitivity benefit for radiology residents, helping them properly recommend CT exams for potential lung cancer patients, and 30% specificity benefit for radiologists in lung cancer detection, reducing unnecessary CT exams. The joint research team has previously focused on validating the accuracy of AI, and proved that Lunit INSIGHT CXR, an AI software for analyzing chest X-rays, can accurately detect malignant pulmonary nodules, which can cause lung cancer. In this consecutive study, the team focused on whether AI can affect the performance of medical professionals in finding lung cancers.

For the study, 519 images of cancer-positive and cancer-negative patients were selected from the National Lung Screening Trial (NLST). Eight readers, including three radiology residents and five board-certified radiologists, participated in the reading. By comparing the analysis of the readers and Lunit INSIGHT CXR, the result showed that AI could lead to more efficient and precise diagnosis for both doctors and patients. With AI, radiology residents were able to recommend 28% more chest CT examinations for patients who may have potential risk of lung cancer. Also, radiologists recommended about 30% lesser proportion of unnecessary chest CT examinations in cancer-negative patients.

"The use of AI could help to detect pulmonary nodules accurately with chest X-rays, as well as reduce the need for unnecessary chest CT exams in some patients," said Mannudeep K. Kalra, MD, a radiologist at the MGH and Co-investigator on the study. "This finding can benefit patients by enabling them to avoid unneeded radiation exposure, and it can benefit the healthcare system by preventing certain medical costs."

"Chest X-ray is the firsthand diagnostic tool to detect lung cancer, but it has limitations as it is a compressed 2D rendering of 3D human structures," said Brandon Suh, CEO of Lunit. "An accurate analysis through Lunit INSIGHT CXR can help medical professionals provide diagnosis to patients with increased efficiency - preventing potential cancer at an early stage, while saving time and cost for those who do not need a further examination."

Related Links:

Massachusetts General Hospital
Lunit Inc.



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.